Search results for "investigational cancer drug"

Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial

Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial

Boryung announced on the 19th that it has completed patient enrollment for the Phase 2 clinical trial of its next-generation targeted cancer therapy...
FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

CAR-T therapy for blood cancers conventionally involves removing a patient’s immune cells, modifying them in a laboratory to attack cancer cells, and...
GC Pharma’s Homegrown mRNA Vaccine Advances to Phase 2 Trials

GC Pharma’s Homegrown mRNA Vaccine Advances to Phase 2 Trials

GC Pharma announced on the 11th that South Korea’s Ministry of Food and Drug Safety has approved its Phase 2 clinical...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate

FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate

Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
LigaChemBio Receives Milestone from Czech Sotio Biotech

LigaChemBio Receives Milestone from Czech Sotio Biotech

LigaChem Biosciences announced on the 9th that it will receive milestone payments based on successful product...
SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals

SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals

SK Biopharm announced on the 12th that it has received approval from the U.S. Food and Drug Administration for the...
Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial

Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial

Abl Bio announced on the 7th that it has confirmed positive anti-cancer efficacy in the dose expansion cohort of the...
Personalized Cancer Vaccine That 'Remembers Cancer' Opens New Pathways

Personalized Cancer Vaccine That 'Remembers Cancer' Opens New Pathways

A domestic research team has developed artificial intelligence -based personalized cancer vaccine design technology...